SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
ATRenew Inc. (RERE) trades at a trailing P/E of 33.2, forward P/E of 1.6. Trailing earnings yield is 3.01%, forward earnings yield 61.73%. PEG 0.01 (Peter Lynch undervalued ≤1.0). Graham Number is $15.13.
Criteria proven by this page:
- VALUE (55/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 1.6 (down from trailing 33.2) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.01 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 3.01% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 61.73% as earnings recover.
Overall SharesGrow Score: 64/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
55/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — RERE
Valuation Multiples
P/E (TTM)33.2
Forward P/E1.6
PEG Ratio0.01
Forward PEG0.01
P/B Ratio2.78
P/S Ratio0.53
EV/EBITDA18.6
Per Share Data
EPS (TTM)$0.92
Forward EPS (Est.)$2.96
Book Value / Share$11.02
Revenue / Share$57.84
FCF / Share$0.00
Yields & Fair Value
Earnings Yield3.01%
Forward Earnings Yield61.73%
Dividend Yield2.23%
Graham Number$15.13
SharesGrow IV$58.68 (+1122.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2018 |
-3.2 |
0.00 |
-0.36 |
0.20 |
- |
| 2019 |
-2.1 |
-0.04 |
-0.44 |
0.38 |
- |
| 2020 |
-1.8 |
-0.15 |
-0.16 |
0.17 |
- |
| 2021 |
-4.1 |
0.05 |
0.52 |
0.43 |
- |
| 2022 |
-2.0 |
-0.19 |
1.25 |
0.49 |
- |
| 2023 |
-21.2 |
0.23 |
0.89 |
0.26 |
- |
| 2024 |
-619.3 |
6.54 |
1.38 |
0.31 |
- |
| 2025 |
41.1 |
-0.02 |
3.37 |
0.66 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2018 |
$-37.32 |
$3.26B |
$-207.94M |
-6.4% |
| 2019 |
$-56.18 |
$3.93B |
$-704.89M |
-17.9% |
| 2020 |
$-63.01 |
$4.86B |
$-470.62M |
-9.7% |
| 2021 |
$-9.17 |
$7.78B |
$-816.55M |
-10.5% |
| 2022 |
$-10.11 |
$9.87B |
$-2.47B |
-25% |
| 2023 |
$-0.64 |
$12.97B |
$-156.25M |
-1.2% |
| 2024 |
$-0.03 |
$16.33B |
$-8.23M |
-0.1% |
| 2025 |
$0.89 |
$20.47B |
$327.13M |
1.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$2.93 |
$2.82 – $3.00 |
$26.12B |
$25.39B – $26.63B |
2 |
| 2027 |
$4.14 |
$3.98 – $4.23 |
$31.78B |
$30.89B – $32.4B |
2 |
| 2028 |
$4.77 |
$4.58 – $4.87 |
$38.39B |
$38.44B – $38.51B |
1 |
